1. Pianka MA, Serino J, DeFroda SF, Bodendorfer BM. Greater
trochanteric pain syndrome: Evaluation and management of a
wide spectrum of pathology. SAGE Open Med.2021;
9:20503121211022582. doi:10.1177/20503121211022582.
2. Bird PA, Oakley SP, Shnier R, Kirkham BW. Prospective
evaluation of magnetic resonance imaging and physical
examination findings in patients with greater trochanteric
pain syndrome. Arthritis Rheum.2001; 44(9):2138-45.
doi:10.1002/1529 0131(200109)44:9<2138::Aidart367>3.0.Co;2-m.
3. Fearon AM, Cook JL, Scarvell JM, Neeman T, Cormick W, Smith
PN. Greater trochanteric pain syndrome negatively affects
work, physical activity and quality of life: a case control study.
J Arthroplasty.2014; 29(2):383-6.
doi:10.1016/j.arth.2012.10.016.
4. Dancy ME, Alexander AS, Clark CJ, et al. Gluteal Tendinopathy:
Critical Analysis Review of Current Nonoperative Treatments.
JBJS Rev.2023; 11(10). doi: 10.2106/JBJS.RVW.23.00101.
5. Gomez LP, Childress JM, eds. Greater Trochanteric Pain
Syndrome (Greater Trochanteric Bursitis).1st Ed. In:
StatPearls [Internet]. Treasure Island (FL): StatPearls
Publishing; 2025.
6. Lee S, Naimark M, Bedi A. Soft tissue repairs in the peritrochanteric space. Annals of Joint. 2018; 3.
7. Redmond JM, Chen AW, Domb BG. Greater Trochanteric Pain
Syndrome. J Am Acad Orthop Surg. 2016; 24(4):231-40.
doi:10.5435/jaaos-d-14-00406.
8. Chowdhury R, Naaseri S, Lee J, Rajeswaran G. Imaging and
management of greater trochanteric pain syndrome. Postgrad
Med J.2014; 90(1068):576-81. doi:10.1136/postgradmedj2013-131828.
9. Torres A, Fernández-Fairen M, Sueiro-Fernández J. Greater
trochanteric pain syndrome and gluteus medius and minimus
tendinosis: nonsurgical treatment. Pain Manag.2018; 8(1):45-
55. doi:10.2217/pmt-2017-0033.
10. Rodeo SA. Orthobiologics: Current Status in 2023 and Future
Outlook. J Am Acad Orthop Surg.2023; 31(12):604-613.
doi:10.5435/jaaos-d-22-00808.
11. Kumar A, Kadamb AG, Kadamb KG. Mesenchymal or
maintenance stem cell & understanding their role in
osteoarthritis of the knee joint: A review article. Arch Bone Jt
Surg.2020; 8(5):560. doi: 10.22038/abjs.2020.42536.2155.
12. Reid D. The management of greater trochanteric pain
syndrome: A systematic literature review. J Orthop.2016;
13(1):15-28. doi:10.1016/j.jor.2015.12.006.
13. Calcei JG, Rodeo SA. Orthobiologics for bone healing. Clinics in
sports medicine.2019; 38(1):79-95. doi:
10.1016/j.csm.2018.08.005.
14. Bradsell H, Waterman B, Lansdown D, Hevesi M, Jones K, Frank
RM. Incorporating Biologics Into Your Sports Medicine
Practice: Who, What, When, Why, and How? Instr Course
Lect.2023; 72:431-444.
15. Shapiro SA, Master Z, Arthurs JR, Mautner K. Tiered approach
to considering orthobiologics for patients with
musculoskeletal conditions. Br J Sports Med.2023; 57(3):179-
180. doi:10.1136/bjsports-2022-106494.
16. Viganò M, Ragni E, Marmotti A, de Girolamo L. The effects of
orthobiologics in the treatment of tendon pathologies: a
systematic review of preclinical evidence. J Exp Orthop.2022;
9(1):31. doi:10.1186/s40634-022-00468-w.
17. Wee J, Thevendran G. The role of orthobiologics in foot and
ankle surgery: Allogenic bone grafts and bone graft
substitutes. EFORT Open Rev.2017; 2(6):272-280.
doi:10.1302/2058-5241.2.160044.
18. Lana J, da Fonseca LF, Macedo RDR, et al. Platelet-rich plasma
vs bone marrow aspirate concentrate: An overview of
mechanisms of action and orthobiologic synergistic effects.
World J Stem Cells.2021; 13(2):155-167.
doi:10.4252/wjsc.v13.i2.155.
19. Pintore A, Notarfrancesco D, Zara A, et al. Intra-articular
injection of bone marrow aspirate concentrate (BMAC) or
adipose-derived stem cells (ADSCs) for knee osteoarthritis: a
prospective comparative clinical trial. J Orthop Surg Res.2023;
18(1):350. doi:10.1186/s13018-023-03841-2.
20. Pereira AA, López BM, de la Serna AR. A Comparative Study
between Hyaluronic Acid and Corticosteroids for the
Treatment of the Greater Trochanteric Pain Syndrome. Open
Journal of Rheumatology and Autoimmune Diseases.2015;
05(03):57-61. doi:10.4236/ojra.2015.53010.
21. Bucher TA, Ebert JR, Smith A, et al. Autologous Tenocyte
Injection for the Treatment of Chronic Recalcitrant Gluteal
Tendinopathy: A Prospective Pilot Study. Orthop J Sports
Med.2017; 5(2):2325967116688866.
doi:10.1177/2325967116688866.
22. Vaishya R, Kumar S, Vaish A, Babu Y. Effectiveness of the
guidelines for the non-operative management of knee
osteoarthritis. Arch Bone Jt Surg.2021; 9(4):472-474. doi:
10.22038/abjs.2020.51112.2535.
23. Moreno-Garcia A, Rodriguez-Merchan EC. Orthobiologics:
current role in orthopedic surgery and traumatology. Arch
Bone Jt Surg.2022; 10(7):536. doi:
10.22038/ABJS.2021.52770.2614.
24. Bashkina AS, Shirokova LY, Knyazeva TS, Parulya OM,
Abrosimova EB, Noskov SM. Application of platelet-rich
plasma in reduction of greater trochanteric pain syndrome.
Traumatology and Orthopedics of Russia. 2011; 17(2):57-61..
doi:10.21823/2311-2905-2011-0-2-57-61.
25. Begkas D, Chatzopoulos ST, Touzopoulos P, Balanika A,
Pastroudis A. Ultrasound-guided Platelet-rich Plasma
Application Versus Corticosteroid Injections for the Treatment of Greater Trochanteric Pain Syndrome: A
Prospective Controlled Randomized Comparative Clinical
Study. Cureus.2020; 12(1):e6583. doi:10.7759/cureus.6583.
26. RR M. Abstracts from the 12th Congress of the European Hip
Society. Hip Int.2016; 26 Suppl 2(2_suppl):3-92.
doi:10.5301/hipint.5000450.
27. Shirokova K, Noskov S, Shirokova L, Gorokhova V. Platelet-rich
plasma treatment in patients with osteoarthritis of the hip and
greater trochanteric pain syndrome. Osteoarthritis and
Cartilage.2018; 26:S144. doi:10.1016/j.joca.2018.02.312.
28. Ribeiro AG, Ricioli WJ, Silva AR, Polesello GC, Guimarães RP.
Prp in the Treatment of Trochanteric Syndrome: A Pilot Study.
Acta Ortop Bras.2016; 24(4):208-212. doi:10.1590/1413-
785220162404159837.
29. Oderuth E, Ali M, Atchia I, Malviya A. A double blind
randomised control trial investigating the efficacy of platelet
rich plasma versus placebo for the treatment of greater
trochanteric pain syndrome (the HIPPO trial): a protocol for a
randomised clinical trial. Trials.2018; 19(1):517.
doi:10.1186/s13063-018-2907-x.
30. Thompson G, Pearson JF. No attributable effects of PRP on
greater trochanteric pain syndrome. N Z Med J.2019;
132(1507):22-32.
31. Jacobson JA, Yablon CM, Henning PT, et al. Greater
Trochanteric Pain Syndrome: Percutaneous Tendon
Fenestration versus Platelet-Rich Plasma Injection for
Treatment of Gluteal Tendinosis. J Ultrasound Med.2016;
35(11):2413-2420. doi:10.7863/ultra.15.11046.
32. Blucher N, Nahas S, Bonatsos V, Patel A, Sarraf K, Vedi V.
Platelet-rich-plasma injections for the treatment of resistant
trochanteric pain. International Journal of Surgery.2016;
36:S32. doi:10.1016/j.ijsu.2016.08.044.
33. Massimi S, LaSalle E, Vongvorachoti J, Lutz GE. Ultrasound‐
Guided Platelet Rich Plasma (PRP) Injections for Greater
Trochanteric Pain Syndrome (GTPS): A Retrospective Case
Series. Pm&R.2013; 5(9S):S206-S207.
doi:10.1016/j.pmrj.2013.08.298.
34. Mautner K, Colberg RE, Malanga G, et al. Outcomes after
ultrasound-guided platelet-rich plasma injections for chronic
tendinopathy: a multicenter, retrospective review. PM&R.
2013; 5(3):169-75. doi:10.1016/j.pmrj.2012.12.010.
35. Unlu MC, Kivrak A, Kayaalp ME, Birsel O, Akgun I.
Peritendinous injection of platelet-rich plasma to treat
tendinopathy: A retrospective review. Acta Orthop Traumatol
Turc.2017; 51(6):482-487. doi:10.1016/j.aott.2017.10.003.
36. Hegarty DA. Abstracts of the 10th World Congress of the World
Institute of Pain (WIP), 26-29 August, 2020, Rome Marriott
Park Hotel - Rome. Pain Pract.2020;20 Suppl 1(S1):7-103.
doi:10.1111/papr.12886.
37. Rajeev A, Yiannis S, Rajpal-Singh K. Abstracts from the 12th
Congress of the European Hip Society. Hip Int.2016; 26 Suppl
2(2_suppl):3-92. doi:10.5301/hipint.5000450.
38. Gorelick L, Rozano-Gorelick A, Robinson D, Marcus O, Joubran
S, Ram E. Treatment of Hip Trochanteric Bursitis Using
Hyaluronate Injections. Open Journal of Rheumatology and
Autoimmune Diseases.2013; 03(02):125-129.
doi:10.4236/ojra.2013.32019.
39. Pereira AA, López BM, de la Serna AR. A Comparative Study
between Hyaluronic Acid and Corticosteroids for the
Treatment of the Greater Trochanteric Pain Syndrome. Open
Journal of Rheumatology and Autoimmune Diseases.2015;
5(03):57.
40. Henderson RG, Colberg RE. Pure bone marrow aspirate
injection for chronic greater trochanteric pain syndrome: a
case report. Pain Manag.2018; 8(4):271-275.
doi:10.2217/pmt-2018-0008.
41. Fitzpatrick J, Bulsara MK, O'Donnell J, McCrory PR, Zheng MH.
The Effectiveness of Platelet-Rich Plasma Injections in Gluteal
Tendinopathy: A Randomized, Double-Blind Controlled Trial
Comparing a Single Platelet-Rich Plasma Injection With a
Single Corticosteroid Injection. Am J Sports Med.2018;
46(4):933-939. doi:10.1177/0363546517745525.
42. Lee JJ, Harrison JR, Boachie-Adjei K, Vargas E, Moley PJ.
Platelet-Rich Plasma Injections with Needle Tenotomy for
Gluteus Medius Tendinopathy: A Registry Study with
Prospective Follow-up. Orthop J Sports Med.2016;
4(11):2325967116671692.
doi:10.1177/2325967116671692.
43. Walker-Santiago R, Wojnowski NM, Lall AC, Maldonado DR,
Rabe SM, Domb BG. Platelet-Rich Plasma Versus Surgery for
the Management of Recalcitrant Greater Trochanteric Pain
Syndrome: A Systematic Review. Arthroscopy.2020;
36(3):875-888. doi:10.1016/j.arthro.2019.09.044.
44. Fitzpatrick J, Bulsara M, Zheng MH. The Effectiveness of
Platelet-Rich Plasma in the Treatment of Tendinopathy: A
Meta-analysis of Randomized Controlled Clinical Trials. Am J
Sports Med.2017; 45(1):226-233.
doi:10.1177/0363546516643716.
45. Migliorini F, Kader N, Eschweiler J, Tingart M, Maffulli N.
Platelet-rich plasma versus steroids injections for greater
trochanter pain syndrome: a systematic review and metaanalysis. Br Med Bull.2021; 139(1):86-99.
doi:10.1093/bmb/ldab018.
46. Yan R, Gu Y, Ran J, et al. Intratendon Delivery of LeukocytePoor Platelet-Rich Plasma Improves Healing Compared With
Leukocyte-Rich Platelet-Rich Plasma in a Rabbit Achilles
Tendinopathy Model. Am J Sports Med.2017; 45(8):1909-
1920. doi:10.1177/0363546517694357.
47. Ali M, Oderuth E, Atchia I, Malviya A. The use of platelet-rich
plasma in the treatment of greater trochanteric pain
syndrome: a systematic literature review. J Hip Preserv
Surg.2018; 5(3):209-219. doi:10.1093/jhps/hny027.
48. Zhou Y, Zhang J, Wu H, Hogan MV, Wang JH. The differential
effects of leukocyte-containing and pure platelet-rich plasma
(PRP) on tendon stem/progenitor cells - implications of PRP
application for the clinical treatment of tendon injuries. Stem
Cell Res Ther.2015; 6(1):173. doi:10.1186/s13287-015-0172-4.
49. Boyd M, Vijayaraghavan N, Karvelas K. Evidenced-Based
Management of Greater Trochanteric Pain Syndrome. Current
Physical Medicine and Rehabilitation Reports.2020; 8(4):313-
321. doi:10.1007/s40141-020-00294-0.
)